SCHEMBL6617322

SCHEMBL6617322

O=C(O)C1CCN2C(=O)CCC3C=CC=CC3=C2C1

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NEK2 P51955 1/20 0.32
KDM4E B2RXH2 1/20 0.31
CYP2C19 P33261 1/20 0.31
POLB P06746 1/20 0.31
GAA P10253 1/20 0.31
GABRP O00591 1/20 0.31
GABRD O14764 1/20 0.31
GABRA1 P14867 1/20 0.31
GABRB1 P18505 1/20 0.31
GABRG2 P18507 1/20 0.31
GABRR1 P24046 1/20 0.31
GABRB3 P28472 1/20 0.31
GABRA5 P31644 1/20 0.31
GABRA3 P34903 1/20 0.31
GABRA2 P47869 1/20 0.31
GABRB2 P47870 1/20 0.31
GABRA4 P48169 1/20 0.31
GABRE P78334 1/20 0.31
GABRA6 Q16445 1/20 0.31
GABRG1 Q8N1C3 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1076292 0.77 KDM4E (0.38) NEK2KDM4ECYP2C19
SCHEMBL7444574 0.71
SCHEMBL12494195 0.65 AKR1C3 (0.35)
SCHEMBL11011371 0.64 TSHR (0.38) CYP2C19
SCHEMBL6473164 0.64 SMN1; SMN2 (0.38) KDM4EPOLB
SCHEMBL9559055 0.63 KDM4C (0.31)
SCHEMBL12494305 0.61 AKR1C3 (0.33)
SCHEMBL12494302 0.61
SCHEMBL8305161 0.61 NOTUM (0.54)
SCHEMBL5326027 0.61 ITGB3 (0.45) NEK2KDM4ECYP2C19POLBGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1381605-A1 MERCAPTOACETYLAMIDE DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND THEIR USE Aventis Pharma Deutschland GmbH (DE) 2004-01-21 EP claimed
WO-2002083671-A1 MERCAPTOACETYLAMIDE DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND THEIR USE AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2002-10-24 WO claimed
EP-0751774-A1 HYPOCHOLESTEROLEMIC, ANTIATHEROSCLEROTIC AND HYPOTRIGLYCERIDEMIC MERCAPTOACETYLAMIDE DISULFIDE DERIVATIVES MERRELL PHARMACEUTICALS INC. (US) 1997-01-08 EP claimed
WO-1995025519-A1 HYPOCHOLESTEROLEMIC, ANTIATHEROSCLEROTIC AND HYPOTRIGLYCERIDEMIC MERCAPTOACETYLAMIDE DISULFIDE DERIVATIVES MERRELL PHARMACEUTICALS INC. (US) 1995-09-28 WO claimed
EP-1381605-A1 MERCAPTOACETYLAMIDE DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND THEIR USE Aventis Pharma Deutschland GmbH (DE) 2004-01-21 EP disclosed
WO-2002083671-A1 MERCAPTOACETYLAMIDE DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND THEIR USE AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2002-10-24 WO disclosed
EP-0751774-A1 HYPOCHOLESTEROLEMIC, ANTIATHEROSCLEROTIC AND HYPOTRIGLYCERIDEMIC MERCAPTOACETYLAMIDE DISULFIDE DERIVATIVES MERRELL PHARMACEUTICALS INC. (US) 1997-01-08 EP disclosed
WO-1995025519-A1 HYPOCHOLESTEROLEMIC, ANTIATHEROSCLEROTIC AND HYPOTRIGLYCERIDEMIC MERCAPTOACETYLAMIDE DISULFIDE DERIVATIVES MERRELL PHARMACEUTICALS INC. (US) 1995-09-28 WO disclosed